AVITA Medical Reports Fourth Quarter and Full-Year 2023 Fina

VALENCIA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin

Related Keywords

Germany , Japan , Valencia , Carabobo , Venezuela , Austria , Switzerland , Australia , United States , Australian , Jim Corbett , Nasdaq , Us Department Of Health , Drug Administration , Biomedical Advanced Research , Development Authority , Human Services , Drug Administration Food , Chief Executive , Biosynthetic Wound Matrix , Assistant Secretary , Conference Call , Eastern Daylight Time , Spray On Skin , Private Securities Litigation Reform Act , Annual Report , Chief Financial Officer , Media Contact , Jessica Ekeberg Phone , Region ,